Cannabis stocks remain under pressure after President Donald Trump signed an executive order Thursday directing the Department of Justice to reschedule marijuana as a lower-class drug. The Department ...

After logging a 1.6% gain during regular trading hours today, Tilray Brands (NASDAQ: TLRY) is racing higher in after-hours ...

Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora ...

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.

U.S. cannabis stocks appear to have completed their post-Executive Order pullback, says Beacon Securities analyst Russell ...

Cannabis investors may be feeling bullish entering 2026 after marijuana rescheduling, but some more advances are needed for ...

Tilray stock price has been highly volatile in the past few months as investors focused on Donald Trump’s cannabis ...

Analysts covering the sector have turned more constructive on cannabis stocks, citing improved regulatory clarity and ...

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.

Cannabis stocks once soared to billion-dollar valuations, but now trade at penny stock levels after the hype faded. 40 U.S. states allow medical marijuana, 24 permit recreational use, yet federal ...

Cannabis stocks surged in 2018-2019 on federal legalization hopes but crashed as progress stalled. Recent news of Trump’s potentially rescheduling marijuana and a Democratic descheduling bill sparked ...

Federal rescheduling efforts, coupled with improved corporate balance sheets, may finally unlock long-awaited profitability for cannabis-sector leaders.